GARABED EKNOYAN to United States
This is a "connection" page, showing publications GARABED EKNOYAN has written about United States.
Connection Strength
0.290
-
A historical perspective of how public policy shaped dialysis care delivery in the United States. Semin Dial. 2020 01; 33(1):5-9.
Score: 0.054
-
The wonderful apparatus of John Jacob Abel called the "artificial kidney". Semin Dial. 2009 May-Jun; 22(3):287-96.
Score: 0.026
-
Emergence of quantification in clinical investigation and the quest for certainty in therapeutics: the road from Hammurabi to Kefauver. Adv Chronic Kidney Dis. 2005 Jan; 12(1):88-95.
Score: 0.019
-
Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). Am J Kidney Dis. 2003 Oct; 42(4):617-22.
Score: 0.017
-
The national epidemic of chronic kidney disease. What we know and what we can do. Postgrad Med. 2001 Sep; 110(3):23-9: quiz 8.
Score: 0.015
-
NKF and RPA collaborating on clinical practice guidelines for chronic kidney disease. Nephrol News Issues. 2001 Jul; 15(8):13, 54.
Score: 0.015
-
Continuous quality improvement: DOQI becomes K/DOQI and is updated. National Kidney Foundation's Dialysis Outcomes Quality Initiative. Am J Kidney Dis. 2001 Jan; 37(1):179-194.
Score: 0.014
-
NKF-K/DOQI Clinical Practice Guidelines: Update 2000. Foreword. Am J Kidney Dis. 2001 Jan; 37(1 Suppl 1):S5-6.
Score: 0.014
-
Lessons from the Hemodialysis (HEMO) Study: an improved measure of the actual hemodialysis dose. Am J Kidney Dis. 1999 Jan; 33(1):142-9.
Score: 0.013
-
An overview of the National Kidney Foundation-Dialysis Outcomes Quality Initiative Implementation. Adv Ren Replace Ther. 1999 Jan; 6(1):3-6.
Score: 0.013
-
The NKF research and training program: a report to its alumni and supporters and a promise for the future. National Kidney Foundation. Am J Kidney Dis. 1998 Dec; 32(6):xlvi-xlviii.
Score: 0.013
-
On the epidemic of cardiovascular disease in patients with chronic renal disease and progressive renal failure: a first step to improve the outcomes. Am J Kidney Dis. 1998 Nov; 32(5 Suppl 3):S1-4.
Score: 0.012
-
Laudatio Joel D. Kopple. Miner Electrolyte Metab. 1998; 24(4):207-10.
Score: 0.012
-
Shaul G. Massry: a man of the world and a scholar for all seasons. Am J Kidney Dis. 1995 Nov; 26(5):797-800.
Score: 0.010
-
On the renal ailments of creators and leaders. Am J Kidney Dis. 1993 Jun; 21(6):653-8.
Score: 0.009
-
Both low muscle mass and low fat are associated with higher all-cause mortality in hemodialysis patients. Kidney Int. 2010 Apr; 77(7):624-9.
Score: 0.007
-
Association of achieved dialysis dose with mortality in the hemodialysis study: an example of "dose-targeting bias". J Am Soc Nephrol. 2005 Nov; 16(11):3371-80.
Score: 0.005
-
Hypertension in older people. Compr Ther. 1983 Dec; 9(12):57-64.
Score: 0.004
-
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003 Jan; 41(1):1-12.
Score: 0.004
-
Estimating the prevalence of low glomerular filtration rate requires attention to the creatinine assay calibration. J Am Soc Nephrol. 2002 Nov; 13(11):2811-2; author reply 2812-6.
Score: 0.004
-
Methods used to evaluate the quality of evidence underlying the National Kidney Foundation-Dialysis Outcomes Quality Initiative Clinical Practice Guidelines: description, findings, and implications. Am J Kidney Dis. 2000 Jul; 36(1):1-11.
Score: 0.003
-
National Kidney Foundation: Dialysis Outcome Quality Initiative--development of methodology for clinical practice guidelines. Nephrol Dial Transplant. 1997 Oct; 12(10):2060-3.
Score: 0.003
-
Urinary biomarkers to detect significant effects of environmental and occupational exposure to nephrotoxins. II. Nephrotoxins of significant frequency and economic impact. Ren Fail. 1997 Jul; 19(4):523-34.
Score: 0.003